Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D03POE
|
|||
Former ID |
DNC005899
|
|||
Drug Name |
2-[(2,2-diphenylacetyl)amino]benzoic acid
|
|||
Synonyms |
2-[(2,2-diphenylacetyl)amino]benzoic Acid; CHEMBL196755; 2-[(diphenylacetyl)amino]benzoic acid; Oprea1_593830; Oprea1_339985; MLS001143352; AC1N2C22; MolPort-001-015-645; HMS2781B19; ZINC3466236; BDBM50174204; STK004896; AKOS003244646; MCULE-3235692188; 2-(2,2-diphenylacetylamino)benzoic acid; SMR000473187
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C21H17NO3
|
|||
Canonical SMILES |
C1=CC=C(C=C1)C(C2=CC=CC=C2)C(=O)NC3=CC=CC=C3C(=O)O
|
|||
InChI |
1S/C21H17NO3/c23-20(22-18-14-8-7-13-17(18)21(24)25)19(15-9-3-1-4-10-15)16-11-5-2-6-12-16/h1-14,19H,(H,22,23)(H,24,25)
|
|||
InChIKey |
NDZQPXFPOCTXEF-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Dihydrodiol dehydrogenase type I (AKR1C3) | Target Info | Inhibitor | [1] |
BioCyc | Superpathway of steroid hormone biosynthesis | |||
Allopregnanolone biosynthesis | ||||
Androgen biosynthesis | ||||
KEGG Pathway | Steroid hormone biosynthesis | |||
Arachidonic acid metabolism | ||||
Metabolic pathways | ||||
Ovarian steroidogenesis | ||||
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | |||
Pathwhiz Pathway | Arachidonic Acid Metabolism | |||
Reactome | Retinoid metabolism and transport | |||
WikiPathways | Metapathway biotransformation | |||
Benzo(a)pyrene metabolism | ||||
Arachidonic acid metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | Nonsteroidal anti-inflammatory drugs and their analogues as inhibitors of aldo-keto reductase AKR1C3: new lead compounds for the development of ant... Bioorg Med Chem Lett. 2005 Dec 1;15(23):5170-5. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.